Recent studies have shown that sphingosine d18:1 can inhibit the interaction between HIF-2α and ARNT, thus suppressing the transcriptional activity of HIF-2α in hepatic macrophages, which in turn promotes NASH [110]. The gene discussed is EPAS1; the disease is metabolic dysfunction-associated steatohepatitis.